SEMAGLUTIDE 14MG TABLETS 30``S

SEMAGLUTIDE 14MG TABLETS 30“S

KSh93,030.00

Rybelsus is the first and only oral formulation of Semaglutide, a GLP-1 receptor agonist used for the treatment of type 2 diabetes mellitus. It mimics the effects of endogenous GLP-1, enhancing glucose-dependent insulin secretion, decreasing glucagon release, slowing gastric emptying, and promoting satiety. These actions help reduce blood glucose levels and contribute to weight loss in many patients.

Unlike injectable GLP-1 agonists, Rybelsus is taken orally, offering a more convenient alternative for patients who prefer tablets over injections. It is especially useful in early treatment intensification, either as monotherapy or as part of combination therapy.

Rybelsus is not insulin and is not intended for use in type 1 diabetes or diabetic ketoacidosis. It also has demonstrated cardiovascular benefits in patients with established cardiovascular disease.

What is type 2 diabetes?

Type 2 diabetes is a condition in which your body does not make enough insulin, and the insulin that your body makes does not lower your blood sugar the way it should. In some cases, your body can produce too much blood sugar. If your blood sugar increases and remains high over a long period of time, this can lead to harmful effects such as heart problems, kidney disease, eye disorders and poor circulation in your limbs. That is why it is important to keep your blood sugar levels within a normal range.

Submit Prescription
Add to wishlist
SKU: DP22614 Category:

Description

INDICATIONS

Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise

• as monotherapy when metformin is considered inappropriate due to intolerance or contraindications.

• in combination with other medicinal products for the treatment of diabetes.

Off-label: Weight management in obese patients (under physician guidance)

DIRECTIONS FOR USE

Dosage:

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

The starting dose of semaglutide is 3 mg once daily for one month. After one month, the dose should be increased to a maintenance dose of 7 mg once daily. After at least one month with a dose of 7 mg once daily, the dose can be increased to a maintenance dose of 14 mg once daily to further improve glycaemic control.

The recommended single daily maintenance doses are 7 mg or 14 mg.

The maximum recommended single daily dose of semaglutide is 14 mg. Rybelsus should always be used as one tablet per day. Taking more than one tablet a day should not be done to achieve the effect of a higher dose.

How to take:

Take your Rybelsus® tablet on an empty stomach after a recommended fasting period of at least 8 hours.

Swallow your Rybelsus® tablet whole with a sip of water (up to 120 ml). Do not split, crush or chew the tablet, as it is not known if it affects absorption of semaglutide.

After taking your Rybelsus® tablet wait at least 30 minutes before eating, drinking or taking other oral medicines. Waiting less than 30 minutes lowers the absorption of semaglutide.

SIDE EFFECTS

Nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, fatigue, headache, dizziness, indigestion, burping, injection site reactions, flatulence, increased heart rate

PREGNANCY AND LACTATION

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

ACTIVE INGREDIENTS

Each tablet contains 14 mg semaglutide

Related products

https://sinaboi.desa.id/wp-includes/depo25/

https://ulstergrandprix.net/

https://odorem-dz.com/

Let's Chat